Morgan Stanley analyst Erik Woodring reiterated an 'Overweight' rating on CDW and slightly increased the price target from $170 to $171. This indicates a continued positive outlook for the company, though the modest price target adjustment suggests a minor update to their valuation model rather than a significant new development.
Morgan Stanley analyst Erik Woodring maintained an 'Overweight' rating on CDW and raised the price target from $170 to $171. This action signals continued confidence in CDW's performance and future prospects from a prominent investment bank. While the price target increase is minor, it reinforces a positive sentiment for the stock. For traders, this could provide a slight short-term positive bump due to analyst endorsement, but the long-term implications are more about sustained positive sentiment rather than a new, major catalyst. The key opportunity for traders is to potentially capitalize on any brief upward momentum following this news, though the small change limits its overall impact.